NEWS
JOHNSON & JOHNSON MEDTECH ANNOUNCES CE MARK APPROVAL FOR DUAL ENERGY THERMOCOOL SMARTTOUCH SF CATHETER
Johnson & Johnson MedTech , a global leader in cardiac arrhythmia treatment , has announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter for the treatment of cardiac arrhythmias . The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is an irrigated , contact-force sensing catheter powered by the TRUPULSE Generator , and is fully integrated with the CARTO 3 System for electro-anatomical mapping and for tag indexing . The company expects TRUPULSE Generator hardware compatibility in the first half of 2025 . When fully approved , the platform will provide electrophysiologists with the ability to switch between radiofrequency ( RF ) and pulsed field ( PF ) energy in the same catheter they know and trust . The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is not currently approved in the United States . The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is designed on the same platform as the radiofrequency THERMOCOOL SMARTTOUCH SF Catheter – the most commonly used catheter in the world today , with many years of physician experience .
“ As the number of people with AFib grows around the world , physicians are looking for integrated and flexible tools to help deliver safe , effective and efficient cardiac ablation procedures ,” said Tom De Potter , MD , Head of Electrophysiology and Associate Director of the Heart Centre , OLV Hospital , Aalst , Belgium . “ Both PF and RF energy have important advantages in clinical practice . With the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter , having the ability to easily switch between RF and PF energy provides the flexibility to customise treatment depending on the patient anatomy and clinical need , enabling electrophysiologists to perform more targeted ablation procedures which could lead to improved outcomes for patients .”
TEMPUS ANNOUNCES NATIONAL LAUNCH OF OLIVIA , ITS AI-ENABLED PERSONAL HEALTH CONCIERGE APP FOR PATIENTS
Tempus AI , a technology company leading the adoption of AI to advance precision medicine and patient care , has announced the national launch of olivia . olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide actionable insights .
olivia is designed to address two core objectives – centralising patients ’ health data and making that data accessible and actionable through AI . The app enables patients to bring their health information into one unified platform . Patients can connect directly to over 1,000 health systems through electronic health record ( EHR ) integration , sync data from health devices to track daily metrics or manually upload health records . olivia then organises that data into a dynamic timeline where patients can access their records , including lab results , imaging reports , visit summaries and even deep clinical data such as DICOM images , which can be shared directly with a patient ’ s care team .
olivia ’ s AI-enabled capabilities allow patients to ask questions about their records , summarise their health information and receive responses informed by their data ; for instance , patients can query , ‘ summarise my health status ,’ and olivia will provide a clear , concise summary of information in your health data . Additionally , olivia connects to external resources , such as clinicaltrials . gov , to supplement the personalised insights offered from existing health data . �
12 www . intelligenthealth . tech